Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical University of South Carolina
With
American Society for Gastrointestinal Endoscopy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Randomization, as detailed below, is stratified by etiology of the stricture: chronic pancreatitis and postoperative (such as post-liver transplant).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Bismuth Type I benign bile duct stricture
Objective signs/symptoms related to the stricture
You may not be if
Suspected malignant etiology for the stricture
Prior endotherapy within one year of presentation,except in the following two scenarios: 1) Early (\< 30 days) stent placement following liver transplant; 2) in patients with chronic pancreatitis, single plastic stent placed during presenting ERCP while evaluating for malignancy
Bismuth Type II-IV stricture
Proximal common hepatic duct diameter \< 6 mm
Intact gallbladder, except in cases where a stent can be deployed \> 1cm below the cystic duct insertion
Age \< 18 years, pregnancy, incarceration, inability to provide informed consent
Karnofsky score ≤ 40
Inability to pass a guidewire proximal to the stricture
Stricture \> 8cm in length
Life expectancy \< 1 year
Concomitant nonanastomotic biliary strictures or biliary casts
Clareo Health | Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures
